| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-12 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-09 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.3 | 7e-08 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |